Atlas Trials

Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema

Clinical trial NCT04739306 · COMPLETED

Trial details

NCT number
NCT04739306
Sponsor
Celltrion
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Macular Edema (DME)
Start date
2021-07-22
Primary completion
2022-10-14
Enrollment
348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.